Skip to content

Clinical trials

Myasthenia Gravis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myasthenia Gravis Country / region: United States Clear all

141 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20042
20061
20082
20091
20104
20112
20121
20134
20142
20154
20163
20174
20185
201914
20204
202113
202210
202310
202423
202511
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting47
Active, not recruiting17
Terminated13
Unknown status5
Enrolling by invitation3
Withdrawn3
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx16
Alexion Pharmaceuticals, Inc.13
UCB Biopharma SRL10
Yale University4
Immunovant Sciences GmbH3
Janssen Research & Development, LLC3
Novartis Pharmaceuticals3
Ad scientiam2
Amgen2
BioSensics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myasthenia Gravis141
Autoimmune Diseases11
Multiple Sclerosis11
Amyotrophic Lateral Sclerosis6
Autoimmune Diseases of the Nervous System6
Stroke6
Muscle Weakness5
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating5
Alzheimer Disease4
Brain Injuries, Traumatic4

Trials

Showing 26 to 50 of 141. Each trial links to its page on Pharma Observatory.

41 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.